ArticlePharmacoEconomics2026

Correction: Balancing Access and Value in Multi‑Indication Medicines: Implications of PD‑(L)1 Broad Listings in Australia.

Isaiah Luc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.